flow trial semaglutide kidney outcomes nejm 2024 hazard ratio FLOW: Kidney outcome results for GLP-1RA flow trial semaglutide kidney outcomes

10.1126/scisignal.aat9900 225 SauberanJ

MOTS-c, mitochondrial support Retatrutide produces the strongest metabolic switch of all incretin peptides, the thermogenic effect means mitochondria are working at higher gear

At TrimRx, we believe that understanding your options is the first step toward a healthier future, and a free assessment quiz can help you see whether a personalized program may be right for you

[DOI] [PMC free article] [PubMed] [Google Scholar] 100.Liu L, Shi H, Liu Y, Anderson A, Peterson J, Greger J, Martin AM, Gilmer TM

Impact of multiple different high-fat diets on metabolism, inflammatory markers, dysbiosis, and liver histology: study on NASH rat model induced diet

1,4 GLP-1 Receptor Agonists and Their Clinical Importance GLP-1 receptor agonists, including semaglutide and liraglutide, have become central to the treatment of type 2 diabetes and obesity due to their demonstrated efficacy in glycemic control and weight reduction